🚀 VC round data is live in beta, check it out!
SIGA Technologies Valuation Multiples
Discover revenue and EBITDA valuation multiples for SIGA Technologies and similar public comparables like NervGen Pharma, Knight Therapeutics, TaiMed Biologics, Regenxbio and more.
SIGA Technologies Overview
About SIGA Technologies
SIGA Technologies Inc is a commercial-stage pharmaceutical company focused on the health security market. The company's main product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by the variola virus. The company derives maximum revenue from United States.
Founded
1995
HQ
Employees
46
Website
Sectors
Financials (LTM)
EV
$291M
SIGA Technologies Financials
SIGA Technologies reported last 12-month revenue of $88M and EBITDA of $20M.
In the same LTM period, SIGA Technologies generated $61M in gross profit, $20M in EBITDA, and $20M in net income.
Revenue (LTM)
SIGA Technologies P&L
In the most recent fiscal year, SIGA Technologies reported revenue of $95M and EBITDA of $24M.
SIGA Technologies expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $88M | XXX | $95M | XXX | XXX | XXX |
| Gross Profit | $61M | XXX | $45M | XXX | XXX | XXX |
| Gross Margin | 69% | XXX | 48% | XXX | XXX | XXX |
| EBITDA | $20M | XXX | $24M | XXX | XXX | XXX |
| EBITDA Margin | 22% | XXX | 26% | XXX | XXX | XXX |
| EBIT Margin | 22% | XXX | 25% | XXX | XXX | XXX |
| Net Profit | $20M | XXX | $23M | XXX | XXX | XXX |
| Net Margin | 22% | XXX | 25% | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
SIGA Technologies Stock Performance
SIGA Technologies has current market cap of $463M, and enterprise value of $291M.
Market Cap Evolution
SIGA Technologies' stock price is $6.46.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $291M | $463M | 0.0% | XXX | XXX | XXX | $0.33 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialSIGA Technologies Valuation Multiples
SIGA Technologies trades at 3.3x EV/Revenue multiple, and 14.8x EV/EBITDA.
EV / Revenue (LTM)
SIGA Technologies Financial Valuation Multiples
As of March 21, 2026, SIGA Technologies has market cap of $463M and EV of $291M.
Equity research analysts estimate SIGA Technologies' 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
SIGA Technologies has a P/E ratio of 23.5x.
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $463M | XXX | $463M | XXX | XXX | XXX |
| EV (current) | $291M | XXX | $291M | XXX | XXX | XXX |
| EV/Revenue | 3.3x | XXX | 3.1x | XXX | XXX | XXX |
| EV/EBITDA | 14.8x | XXX | 12.0x | XXX | XXX | XXX |
| EV/EBIT | 15.2x | XXX | 12.3x | XXX | XXX | XXX |
| EV/Gross Profit | 4.7x | XXX | 6.5x | XXX | XXX | XXX |
| P/E | 23.5x | XXX | 19.9x | XXX | XXX | XXX |
| EV/FCF | — | XXX | 6.8x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified SIGA Technologies Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
SIGA Technologies Margins & Growth Rates
SIGA Technologies' revenue in the last 12 month grew by 11%.
SIGA Technologies' revenue per employee in the last FY averaged $1.9M.
SIGA Technologies' rule of 40 is 34% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
SIGA Technologies' rule of X is 51% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
SIGA Technologies Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 11% | XXX | (30%) | XXX | XXX | XXX |
| EBITDA Margin | 22% | XXX | 26% | XXX | XXX | XXX |
| EBITDA Growth | 62% | XXX | (87%) | XXX | XXX | XXX |
| Rule of 40 | — | XXX | 34% | XXX | XXX | XXX |
| Bessemer Rule of X | — | XXX | 51% | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $1.9M | XXX | XXX | XXX |
| G&A Expenses to Revenue | 24% | XXX | — | XXX | XXX | XXX |
| R&D Expenses to Revenue | 24% | XXX | — | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 22% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
SIGA Technologies Public Comps
See public comps and valuation multiples for other Biopharmaceuticals comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| NervGen Pharma | XXX | XXX | XXX | XXX | XXX | XXX |
| Knight Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
| TaiMed Biologics | XXX | XXX | XXX | XXX | XXX | XXX |
| Regenxbio | XXX | XXX | XXX | XXX | XXX | XXX |
| Newron Pharmaceuticals | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
SIGA Technologies M&A Activity
SIGA Technologies acquired XXX companies to date.
Last acquisition by SIGA Technologies was on XXXXXXXX, XXXXX. SIGA Technologies acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by SIGA Technologies
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialSIGA Technologies Investment Activity
SIGA Technologies invested in XXX companies to date.
SIGA Technologies made its latest investment on XXXXXXXX, XXXXX. SIGA Technologies invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by SIGA Technologies
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout SIGA Technologies
| When was SIGA Technologies founded? | SIGA Technologies was founded in 1995. |
| Where is SIGA Technologies headquartered? | SIGA Technologies is headquartered in United States. |
| How many employees does SIGA Technologies have? | As of today, SIGA Technologies has over 46 employees. |
| Who is the CEO of SIGA Technologies? | SIGA Technologies' CEO is Diem Nguyen. |
| Is SIGA Technologies publicly listed? | Yes, SIGA Technologies is a public company listed on Nasdaq. |
| What is the stock symbol of SIGA Technologies? | SIGA Technologies trades under SIGA ticker. |
| When did SIGA Technologies go public? | SIGA Technologies went public in 1997. |
| Who are competitors of SIGA Technologies? | SIGA Technologies main competitors are NervGen Pharma, Knight Therapeutics, TaiMed Biologics, Regenxbio. |
| What is the current market cap of SIGA Technologies? | SIGA Technologies' current market cap is $463M. |
| What is the current revenue of SIGA Technologies? | SIGA Technologies' last 12 months revenue is $88M. |
| What is the current revenue growth of SIGA Technologies? | SIGA Technologies revenue growth (NTM/LTM) is 11%. |
| What is the current EV/Revenue multiple of SIGA Technologies? | Current revenue multiple of SIGA Technologies is 3.3x. |
| Is SIGA Technologies profitable? | Yes, SIGA Technologies is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of SIGA Technologies? | SIGA Technologies' last 12 months EBITDA is $20M. |
| What is SIGA Technologies' EBITDA margin? | SIGA Technologies' last 12 months EBITDA margin is 22%. |
| What is the current EV/EBITDA multiple of SIGA Technologies? | Current EBITDA multiple of SIGA Technologies is 14.8x. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.